This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
09/01/15 - 1:04:40 PM ET (BATS BZX Real-time Price)
Div Yield: --
HBIO Day's Range
HBIO 52 Week Range
HBIO Business Summary
Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research.View HBIO key stats
Harvard Bioscience Inc - HBIO - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Harvard Bioscience Inc as a
Hold with a ratings score of C.
Report Snippet: We rate HARVARD BIOSCIENCE INC (HBIO) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow.